Mechanistic Study of Broadly Neutralizing Human Monoclonal Antibodies against Dengue Virus That Target the Fusion Loop

Safety and Immunogenicity of a Tetravalent Live-attenuated Dengue Vaccine in Flavivirus Naive Children

(2018) Sriluck Simasathien et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

(2012) R. de Alwis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody

(2012) E. P. Teoh et al.   Science Translational Medicine

Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay

(2012) Hong-En Lin et al.   PLoS Neglected Tropical Diseases

Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus

(2011) Joseph JB Cockburn et al.   EMBO JOURNAL

Development of sanofi pasteur tetravalent dengue vaccine

(2011) Bruno Guy et al.   Human vaccines & immunotherapeutics

Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding

(2011) D. Watterson et al.   JOURNAL OF GENERAL VIROLOGY

Monitoring virus entry into living cells using DiD-labeled dengue virus particles

(2011) Nilda V. Ayala-Nuñez et al.   METHODS

In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection

(2011) Ruklanthi de Alwis et al.   PLoS Neglected Tropical Diseases

A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus

(2011) Kimberly A. Dowd et al.   PLoS Pathogens

Viral entry inhibitors block dengue antibody-dependent enhancement in vitro

(2010) Cindo O. Nicholson et al.   ANTIVIRAL RESEARCH

Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus

(2010) Anwar M. Hashem et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

(2010) Martina Beltramello et al.   Cell Host & Microbe

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

(2010) Wellington Sun et al.   Human vaccines & immunotherapeutics

A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults

(2010) Dennis Morrison et al.   JOURNAL OF INFECTIOUS DISEASES

Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2

(2010) S. Sukupolvi-Petty et al.   JOURNAL OF VIROLOGY

Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City

(2010) Jorge Poo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

(2010) W. Dejnirattisai et al.   SCIENCE

Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial

(2010) Charmagne G. Beckett et al.   VACCINE

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient

(2010) John S Schieffelin et al.   Virology Journal

Structural Optimization and De Novo Design of Dengue Virus Entry Inhibitory Peptides

(2010) Joshua M. Costin et al.   PLoS Neglected Tropical Diseases

Dengue Virus Ensures Its Fusion in Late Endosomes Using Compartment-Specific Lipids

(2010) Elena Zaitseva et al.   PLoS Pathogens

Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance

(2009) Stephen J. Thomas et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Production and characterization of anti-dengue capsid antibodies suggesting the N terminus region covering the first 20 amino acids of dengue virus capsid protein is predominantly immunogenic in mice

(2009) Chunya Puttikhunt et al.   ARCHIVES OF VIROLOGY

Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody

(2009) Mickaël V Cherrier et al.   EMBO JOURNAL

Clonal dissection of the human memory B-cell repertoire following infection and vaccination

(2009) Debora Pinna et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies

(2009) Hua-Xin Liao et al.   JOURNAL OF VIROLOGICAL METHODS

Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step

(2009) M. R. Vogt et al.   JOURNAL OF VIROLOGY

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

(2009) W.M.P.B. Wahala et al.   VIROLOGY

A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes

(2009) Bruce S. Thompson et al.   PLoS Pathogens

A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus

(2008) K. Raviprakash et al.   JOURNAL OF VIROLOGY

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

(2008) C.-Y. Lai et al.   JOURNAL OF VIROLOGY

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins

(2008) Shee-Mei Lok et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Viral membrane fusion

(2008) Stephen C Harrison   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation

(2008) I-M. Yu et al.   SCIENCE

Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses

(2008) John T. Roehrig et al.   VIRAL IMMUNOLOGY